STOCK TITAN

Addus Homecare Corp Form 4 Filings

ADUS NASDAQ

Every Form 4 that Addus Homecare Corp (ADUS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ADUS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ADUS filings page.

Rhea-AI Summary

Addus HomeCare Corp executive Heather Brianne Dixon, President and Chief Operating Officer, reported an open-market sale of 288 shares of common stock at $93.77 per share. According to the disclosure, the sale was made under a previously established Rule 10b5-1 trading plan to cover tax obligations arising from the vesting of restricted stock awards. After this transaction, she continues to hold 44,371 shares of Addus HomeCare common stock directly.

Rhea-AI Summary

Addus HomeCare Corp director Veronica Hill-Milbourne received a grant of restricted common shares as equity compensation. She acquired 1,449 shares at no stated purchase price, increasing her direct holdings to 6,516 shares. These restricted shares were granted as a non-employee director award and will vest in full on June 10, 2027, aligning part of her compensation with the company’s future performance.

Rhea-AI Summary

Lopez Esteban reported acquisition or exercise transactions in this Form 4 filing.

Addus HomeCare Corp director Esteban Lopez reported receiving a grant of 1,449 shares of common stock as a compensation award. These are restricted shares for non-employee directors that will vest in full on June 10, 2027. After the award, Lopez directly holds 4,649 shares.

Rhea-AI Summary

RUSH JEAN reported acquisition or exercise transactions in this Form 4 filing.

Addus HomeCare Corp director Jean Rush received an equity grant of company stock. The Form 4 reports an award of 1,449 shares of Common Stock at no cash cost, increasing her directly held stake to 10,670 shares after the transaction.

According to the footnote, these are restricted shares granted to non-employee directors that will vest in full on June 10, 2027, meaning they are subject to service-based conditions until that date.

Rhea-AI Summary

Weaver Susan T reported acquisition or exercise transactions in this Form 4 filing.

Addus HomeCare Corp director Susan T. Weaver received a grant of 1,449 shares of restricted common stock as compensation. These restricted shares were granted to a non-employee director and will vest in full on June 10, 2027. Following this award, Weaver directly holds 13,744 shares of Addus HomeCare common stock.

Rhea-AI Summary

Addus HomeCare Corp director Darin J. Gordon received 1,449 shares of common stock as a restricted stock grant. The award carries no cash exercise price and increases his direct holdings to 14,244 shares. The restricted shares were granted as compensation for non-employee director service and will vest in full on June 10, 2027.

Rhea-AI Summary

FIRST MARK L reported acquisition or exercise transactions in this Form 4 filing.

Addus HomeCare Corp director Mark L. First received a grant of 1,449 shares of common stock as restricted shares for his service as a non-employee director. These restricted shares were granted at no cash cost to him and will vest in full on June 10, 2027. Following this compensation award, he directly holds 15,070 shares of Addus HomeCare common stock.

Rhea-AI Summary

Addus HomeCare Corp director Michael Earley reported a compensation-related stock grant. He received an award of 1,449 shares of common stock at no cash cost, described as restricted shares granted to non-employee directors that will vest in full on June 10, 2027.

Following this grant, Earley directly holds 13,400 common shares. In addition, 2,695 common shares are reported as indirectly held by Bird Asset Management, LP. The filing reflects an acquisition by grant rather than any open-market buying or selling.

Rhea-AI Summary

Addus HomeCare Corp director Esteban Lopez sold shares in an open-market transaction. On May 21, 2026, he sold 250 shares of Addus HomeCare common stock at a price of $93.00 per share. Following this sale, he directly owns 3,200 shares of the company’s common stock.

Rhea-AI Summary

Addus HomeCare Corp director Esteban Lopez reported an open-market sale of Common Stock. On May 19, 2026, he sold 250 shares at $93.00 per share. After this transaction, Lopez directly holds 3,450 shares of Addus HomeCare common stock.

Rhea-AI Summary

Addus HomeCare Corp executive Cliff Donald Blessing reported a small open-market sale of company stock. As EVP and Chief Development Officer, he sold 178 shares of common stock at $93.61 per share. After this transaction, he directly holds 12,183 shares of Addus HomeCare common stock.

The company states this sale was executed under a previously established Rule 10b5-1 trading plan and was made to cover tax obligations arising from the vesting of restricted stock awards. This indicates the transaction was pre-planned and primarily driven by tax-related needs rather than discretionary trading.

Rhea-AI Summary

Addus HomeCare Corp executive Monica Raines reported an open-market sale of 224 shares of common stock. The transaction occurred at a price of $102.15 per share and was reported as a sale in the open market or a private transaction. After this trade, her directly held stake stood at 13,577 shares of Addus HomeCare common stock.

According to the footnotes, this sale was executed under a previously established Rule 10b5-1 trading plan, adopted on 03-13-2025, and was made to satisfy tax obligations arising from the vesting of restricted stock awards granted by the company.

Rhea-AI Summary

Addus HomeCare Corp executive Monica Raines reported planned stock sales tied to tax obligations. She sold 437 shares of common stock on February 24, 2026 at $106.99 per share and 219 shares on February 25, 2026 at $105.36 per share in open-market transactions.

The filing states these sales were made under a previously established Rule 10b5-1 trading plan to satisfy taxes owed upon the vesting of restricted stock awards. After these transactions, she directly owns 13,801 shares of Addus HomeCare common stock.

Rhea-AI Summary

Addus HomeCare Corp executive Roberton James Stevenson reported two open-market sales of common stock under a pre-set 10b5-1 plan. He sold 567 shares on February 24, 2026 at $107.35 per share and 284 shares on February 25, 2026 at $105.36 per share to cover tax obligations from vesting restricted stock awards. After these transactions, he directly holds 14,030 shares.

Rhea-AI Summary

Addus HomeCare Corp executive Cliff Donald Blessing reported open-market sales of company stock. He sold 350 shares on February 24 at $107.14 per share and 177 shares on February 25 at $105.36 per share. These transactions were made under a previously established Rule 10b5-1 trading plan to satisfy tax obligations from vesting restricted stock awards. After these sales, he directly owns 12,361 common shares.

Rhea-AI Summary

Addus HomeCare Corp executive Michael D. Wattenbarger, EVP and Chief Information Officer, reported selling 892 shares of common stock in two open-market transactions. He sold 592 shares at $107.35 per share and 300 shares at $105.36 per share, all classified as direct ownership.

According to the filing, these sales were made under a previously established Rule 10b5-1 trading plan and were undertaken to satisfy tax obligations arising from the vesting of restricted stock awards granted by Addus. After these transactions, Wattenbarger directly holds 9,444 shares of Addus common stock.

Rhea-AI Summary

Addus HomeCare Corp executive David W. Tucker reported selling company stock in two open-market transactions. As EVP and Chief Strategy Officer, he sold 704 shares of common stock on February 24 at $107.35 per share and 379 shares on February 25 at $105.36 per share.

These sales, totaling 1,083 shares, were made pursuant to a previously established Rule 10b5-1 trading plan to satisfy tax obligations arising from the vesting of restricted stock awards granted by Addus. Following the most recent sale, Tucker directly holds 10,423 shares of Addus common stock.

Rhea-AI Summary

Addus HomeCare Corp executive Anderson Darby reported small planned stock sales under a Rule 10b5-1 plan. On February 24, 2026, Darby sold 733 shares of common stock at an average price of $106.98, followed by 396 shares at $105.36 on February 25, 2026. The footnotes state these sales were made under a previously established 10b5-1 plan to cover tax obligations from vesting restricted stock awards. After these transactions, Darby directly owned 46,246 shares of Addus HomeCare common stock.

Rhea-AI Summary

Addus HomeCare Corp executive Sean Gaffney, EVP and Chief Legal Officer, reported selling 1,259 shares of common stock in open-market transactions under a previously established Rule 10b5-1 trading plan.

The sales occurred on February 24 and 25, 2026, at prices of $106.98 and $105.36 per share. According to the disclosure, the trades were made to satisfy tax obligations arising from the vesting of restricted stock awards. After these transactions, Gaffney directly owned 20,080 shares of Addus common stock.

Rhea-AI Summary

Addus HomeCare Corp EVP and CFO Brian Poff reported open-market sales of 2,861 shares of common stock. The transactions occurred on two days, involving 2,041 shares on one day and 820 shares on the next, at prices a little above $105 per share. According to the footnotes, these sales were executed under a previously established Rule 10b5-1 trading plan and were made to cover tax obligations arising from the vesting of restricted stock awards. After these sales, Poff continues to hold 63,692 shares of Addus HomeCare common stock directly.

Rhea-AI Summary

Addus HomeCare Corp Chairman and CEO Dirk Allison reported selling a total of 7,352 shares of common stock in open-market transactions. He sold 4,988 shares at an average price of $106.98 on February 24 and 2,364 shares at $105.36 on February 25. These sales were made under a previously established Rule 10b5-1 trading plan to cover tax obligations from vesting restricted stock awards. After the transactions, he directly owns 183,150 shares of Addus HomeCare common stock.

Rhea-AI Summary

Addus HomeCare Corp executive Monica Raines reported both a stock award and a small sale of shares. On February 20, 2026, she acquired 2,858 shares of common stock as a grant at $0.00 per share, vesting in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and change-in-control provisions.

On February 23, 2026, she sold 446 shares of common stock in an open-market transaction at an average price of $114.91 per share under a previously established Rule 10b5-1 trading plan to satisfy tax obligations from restricted stock vesting. After these transactions, she directly held 14,457 shares of Addus common stock.

Rhea-AI Summary

Addus HomeCare Corp EVP and Chief HR Officer Roberton James Stevenson reported a stock grant and a related share sale. On February 20, he acquired 2,858 shares of common stock as a grant, at no cost, which vest in equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and potential acceleration upon a change in control. On February 23, he sold 561 shares at $114.91 per share under a pre-set Rule 10b5-1 plan to cover tax obligations from vesting restricted stock awards, leaving 14,881 shares directly owned.

Rhea-AI Summary

Addus HomeCare Corp EVP and Chief Development Officer Cliff Donald Blessing reported mixed share activity. He sold 371 shares of common stock in an open-market transaction at $114.91 per share under a pre-set 10b5-1 plan to cover tax obligations. He also received a grant of 2,858 restricted shares that vest in equal installments on February 20, 2027, February 20, 2028, and February 20, 2029. Following these transactions, he directly holds 12,888 shares.

Rhea-AI Summary

Addus HomeCare Corp executive Michael D. Wattenbarger reported both an equity grant and a small share sale. On February 20, 2026, he acquired 3,117 shares of common stock as a grant with no purchase price, lifting his holdings to 10,913 shares.

The granted shares vest in three equal installments on each of February 20, 2027, 2028, and 2029, subject to continued service and change-in-control provisions. On February 23, 2026, he sold 577 shares at $114.91 per share in an open-market trade under a pre-established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, leaving him with 10,336 directly owned shares.

Rhea-AI Summary

Addus HomeCare Corp executive David W. Tucker reported both an equity award and a small share sale. On February 20, 2026, he acquired 3,429 shares of common stock as a grant or award at no cost. These shares vest in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and customary change-in-control provisions.

On February 23, 2026, Tucker executed an open-market sale of 658 shares of common stock at $114.91 per share. According to the footnote, this sale was made under a previously established Rule 10b5-1 trading plan adopted on March 13, 2025 and was intended to satisfy tax obligations arising from the vesting of restricted stock awards.

Rhea-AI Summary

Addus HomeCare Corp executive Darby Anderson reported mixed share activity. On February 20, 2026, he acquired 3,897 shares of common stock as a grant that will vest in equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and change‑in‑control provisions.

On February 23, 2026, he sold 666 shares of common stock at $114.91 per share in an open‑market transaction under a previously established Rule 10b5‑1 trading plan adopted on March 5, 2025, to cover tax obligations from vesting restricted stock awards. After these transactions, he held 47,375 shares directly.

Rhea-AI Summary

Addus HomeCare Corp EVP and Chief Legal Officer Sean Gaffney reported two stock transactions. He received a grant of 3,897 common shares at no cost, vesting in three equal installments on February 20 of 2027, 2028, and 2029. He then executed an open-market sale of 737 shares at $114.91 under a pre-established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, leaving him with 21,339 directly held shares.

Rhea-AI Summary

Addus HomeCare Corp Executive Vice President and Chief Financial Officer Brian Poff reported two stock transactions. On February 20, 2026, he acquired 11,431 shares of common stock as a grant that will vest in three equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and change-in-control provisions.

On February 23, 2026, he sold 1,858 shares of common stock at $114.91 per share in an open-market transaction pursuant to a previously established Rule 10b5-1 trading plan, to cover tax obligations from restricted stock vesting. After the sale, he directly owned 66,553 shares of Addus common stock.

Rhea-AI Summary

Addus HomeCare Corp reported that President and Chief Operating Officer Heather Brianne Dixon acquired a grant of 12,470 shares of common stock at no cost as equity compensation. These shares vest in equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and change-in-control provisions. Following this grant, she directly holds a total of 44,659 common shares.

Rhea-AI Summary

Addus HomeCare Corp Chairman and CEO Allison R. Dirk reported both a stock grant and a tax-related share sale. He received a grant of 28,576 shares of common stock that vest in equal parts on February 20 of 2027, 2028, and 2029. He also sold 4,535 shares at $114.91 per share under a previously established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, and held 190,502 shares afterward.

Rhea-AI Summary

Addus HomeCare Corp director Esteban Lopez reported selling a total of 150 shares of the company’s common stock on 12/15/2025. The Form 4 discloses two separate sales: 50 shares at a price of $114.55 and 100 shares at $115.50, each recorded as a disposition of common stock. After these transactions, Lopez beneficially owns 3,700 shares of Addus HomeCare common stock in direct ownership.

Rhea-AI Summary

Addus HomeCare Corp executive Darby Anderson, EVP and Chief Government Relations Officer, reported an option exercise and share sale. On 11/19/2025, Anderson exercised 20,000 employee stock options at an exercise price of $22.70 per share, acquiring the same number of Addus HomeCare common shares. On the same date, Anderson sold 20,000 common shares at a price of $109 per share.

After these transactions, Anderson directly beneficially owned 44,144 shares of Addus HomeCare common stock, and held 0 remaining employee stock options. The filing notes that all options involved in this transaction were fully vested.

Rhea-AI Summary

Heather Brianne Dixon, a named officer of Addus HomeCare Corp (ADUS), reported an acquisition on 09/15/2025 of 28,370 shares of the issuer's common stock at a reported price of $0. Following the reported transaction, Ms. Dixon beneficially owns 32,189 shares, held directly. The filing includes an explanatory note that the newly reported shares vest in equal installments on September 15, 2026, September 15, 2027, and September 15, 2028, subject to customary continued-service provisions and acceleration on a change in control. The Form 4 was signed by an attorney-in-fact on 09/16/2025.